Guidelines & Advice

Hematologic Cancer

These guidelines and other documents provide advice for different types of hematologic cancer: non-Hodgkin lymphoma, leukemia, multiple myeloma, Hodgkin lymphoma, myelodysplastic syndrome (MDS) and myelofibrosis.

CAR T-cell Therapy Enrolment

Displaying Guidelines

12 Items

Best Practices for Pathology Secondary Review: Hematologic Cancers

Document Status: Archived
ID: 22-2-6

Jun 2014

Bortezomib in Multiple Myeloma and Lymphoma

Document Status: Archived
ID: 6-18
Version: 2

Jun 2016

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Document Status: In-Review
ID: RR SCT-9
Version: N/A

Jun 2020

Ibritumomab Tiuxetan in Lymphoma

Document Status: Archived
ID: 6-17

Nov 2013

Iodine-131 Tositumomab in Lymphoma

Document Status: Archived
ID: 6-19

Jan 2007

PET Imaging in Lymphoma

Document Status: Current
ID: PET 12

Mar 2015

Rituximab in Lymphoma and Chronic Lymphocytic Leukemia: A Clinical Practice Guideline

Document Status: Archived
ID: 6-8
Version: 3

Mar 2015

Safety Considerations for the Implementation of Subcutaneous Rituximab Formulation

Document Status: Current
Version: 1

Jun 2018

Stem Cell Transplantation in Lymphoma

Document Status: Archived
ID: SCT 4

Dec 2012

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Document Status: Current

Mar 2025

The Use of Chemotherapy and Growth Factors in Older Patients with Newly Diagnosed, Advanced Stage, Aggressive Histology Non-Hodgkin's Lymphoma

Document Status: Education and Information
ID: 6-7 Version 2
Version: 2

Jun 2013

Treatment with Fludarabine for Patients with Follicular and Other Low Grade Non-Hodgkin's Lymphoma and Waldenstrom's Macroglobulinemia

Document Status: Archived
ID: 6-2
Version: 2

Aug 2013